ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,010.60
      0.87%
      US Tech 100
      16,781.60
      0.17%
      Dow Jones
      38,239.98
      0.67%
      Brent Oil
      86.925
      0.60%
      Bitcoin
      66,175.21
      -1.02%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Heron Therapeautics Inc (HRTX)

      7. Heron Therapeautics Inc (HRTX) News

      HRTX Heron Therapeautics Inc

      2.59
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:04:04
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Heron Therapeautics Inc HRTX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 2.59 04:04:04
      Open Price Low Price High Price Close Price Prev Close
      2.59
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      4/11/202416:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
      3/28/202416:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
      3/13/202416:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
      3/12/202416:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
      3/12/202407:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
      2/28/202408:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
      2/14/202416:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/14/202416:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/24/202409:25APSPremarket Heats Up For Biotech Before Opening Bell
      1/24/202408:01EDGAR2Form 8-K - Current report
      1/23/202420:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
      1/19/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/19/202420:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/16/202417:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/11/202416:07EDGAR2Form 8-K - Current report
      1/07/202417:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
      12/22/202316:30EDGAR2Form 8-K - Current report
      12/21/202317:25EDGAR2Form 8-K - Current report
      12/06/202316:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      11/21/202312:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/20/202310:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/17/202312:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/17/202312:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/15/202312:25APSBiotech Shares Up Sharply Following Quarterly Results
      11/14/202316:10EDGAR2Form 8-K - Current report
      11/14/202316:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
      11/07/202316:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
      10/17/202319:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/24/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      8/23/202316:08EDGAR2Form S-3 - Registration statement under Securities Act of..
      8/14/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/14/202316:11EDGAR2Form 8-K - Current report
      8/14/202316:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..
      8/07/202316:05PRNUSHeron Therapeutics to Report Second Quarter 2023 Financial..
      8/01/202313:56EDGAR2Form D - Notice of Exempt Offering of Securities
      7/25/202316:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/25/202316:13EDGAR2Form SC 13D/A - General statement of acquisition of..
      7/24/202309:12EDGAR2Form 8-K - Current report
      7/24/202309:02PRNUSHeron Therapeutics Announces Cost Reduction Plan and..
      7/24/202309:00PRNUSHeron Therapeutics Announces $30 Million Private Placement..
      7/19/202318:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/17/202317:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/17/202317:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

      Your Recent History

      NASDAQ
      HRTX
      Heron Therapeautics
      Delayed Upgrade Clock